TUDCA-ALS | Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)
01-01-2018
-31-12-2023
Show more information
Organisation
BRUSCHETTINI SRL